Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board  >  La Jolla Pharmaceutical Company    

LA JOLLA PHARMACEUTICAL COMPANY
Mes dernières consult.
Most popular
Report
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

LA JOLLA PHARMACEUTICAL COMPANY : REVERSE SPLIT: 1 for 50

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/14/2014 CET
REVERSE SPLIT: 1 for 50


© Factset 2014
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LA JOLLA PHARMACEUTICAL CO
10/30 LA JOLLA PHARMACEUTICAL CO : Results of Operations and Financial Condition, Fina..
10/26 LA JOLLA PHARMACEUTICAL : posts 3Q loss
10/26 LA JOLLA PHARMACEUTICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL COND..
10/26 LA JOLLA PHARMACEUTICAL COMPANY : Announces Financial Results for the Three and ..
10/02 LA JOLLA PHARMACEUTICAL COMPANY (NAS : LJPC) Files An 8-K Other Events
09/29 LA JOLLA PHARMACEUTICAL CO : Other Events, Financial Statements and Exhibits (fo..
09/28 LA JOLLA PHARMACEUTICAL : Prespecified Analysis of ATHOS-3 Indicates Survival Be..
09/27 LA JOLLA PHARMACEUTICAL COMPANY : Featured Company News - La Jolla Pharma Announ..
09/27 LA JOLLA PHARMACEUTICAL COMPANY : Announces Intent to Submit Marketing Authoriza..
09/25 LA JOLLA PHARMACEUTICAL COMPANY : Announces Intent to Submit Marketing Authoriza..
More news
Financials ($)
Sales 2017 -
EBIT 2017 -105 M
Net income 2017 -105 M
Finance 2017 106 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 0
EV / Sales 2018 20,0x
Capitalization 762 M
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 56,4 $
Spread / Average Target 64%
EPS Revisions
Managers
NameTitle
George Francis Tidmarsh President, CEO, Secretary & Director
Kevin C. Tang Chairman
Jennifer Carver Chief Operating Officer
Dennis M. Mulroy Chief Financial & Accounting Officers
Lakhmir S. Chawla Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
LA JOLLA PHARMACEUTICAL COMPANY762
GILEAD SCIENCES1.16%94 693
REGENERON PHARMACEUTICALS6.67%41 304
VERTEX PHARMACEUTICALS100.10%36 699
GENMAB4.43%11 899
EXELIXIS, INC.76.93%7 707